Search research articles
Contact Us
Filters
Showing results (111-120 of 148) with videos related to
Page
of 15
Sort By:
Lancet (London, England)
|
September 3, 1988
Carboplatin or cisplatin?
A H Calvert, A Horwich, E S Newlands, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2000
Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose) polymerase inhibitors in a panel of human tumor cell lines
C A Delaney, L Z Wang, S Kyle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 1995
Clinical pharmacokinetic and pharmacodynamic studies with the nonclassical antifolate thymidylate synthase inhibitor 3, 4-dihydro-2-amino-6-methyl-4-oxo-5-(4-pyridylthio)-quinazolone dihydrochloride (AG337) given by 24-hour continuous intravenous infusion
I Rafi, G A Taylor, J A Calvete, et al.
British Journal of Cancer
|
September 1, 1999
Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced alpha1-acid glycoprotein binding
N J Curtin, K J Bowman, R N Turner, et al.
Journal of Medicinal Chemistry
|
November 7, 2000
Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase
A W White, R Almassy, A H Calvert, et al.
Journal of Medicinal Chemistry
|
May 1, 1991
Quinazoline antifolate thymidylate synthase inhibitors: heterocyclic benzoyl ring modifications
P R Marsham, L R Hughes, A L Jackman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2002
Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial
L Biganzoli, T Cufer, P Bruning, et al.
Seminars in Oncology
|
October 1, 1994
Carboplatin and granulocyte colony-stimulating factor as first-line treatment for epithelial ovarian cancer: a phase I dose-intensity escalation study
A H Calvert, M J Lind, S Ghazal-Aswad, et al.
Journal of Medicinal Chemistry
|
November 1, 1990
Quinazoline antifolate thymidylate synthase inhibitors: benzoyl ring modifications in the C2-methyl series
P R Marsham, A L Jackman, J Oldfield, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1993
Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group
D R Newell, A D Pearson, K Balmanno, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 148) with videos related to
Sort By:
Page
of 15
Lancet (London, England)
|
September 3, 1988
Carboplatin or cisplatin?
A H Calvert, A Horwich, E S Newlands, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2000
Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose) polymerase inhibitors in a panel of human tumor cell lines
C A Delaney, L Z Wang, S Kyle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 1995
Clinical pharmacokinetic and pharmacodynamic studies with the nonclassical antifolate thymidylate synthase inhibitor 3, 4-dihydro-2-amino-6-methyl-4-oxo-5-(4-pyridylthio)-quinazolone dihydrochloride (AG337) given by 24-hour continuous intravenous infusion
I Rafi, G A Taylor, J A Calvete, et al.
British Journal of Cancer
|
September 1, 1999
Potentiation of the cytotoxicity of thymidylate synthase (TS) inhibitors by dipyridamole analogues with reduced alpha1-acid glycoprotein binding
N J Curtin, K J Bowman, R N Turner, et al.
Journal of Medicinal Chemistry
|
November 7, 2000
Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase
A W White, R Almassy, A H Calvert, et al.
Journal of Medicinal Chemistry
|
May 1, 1991
Quinazoline antifolate thymidylate synthase inhibitors: heterocyclic benzoyl ring modifications
P R Marsham, L R Hughes, A L Jackman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2002
Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial
L Biganzoli, T Cufer, P Bruning, et al.
Seminars in Oncology
|
October 1, 1994
Carboplatin and granulocyte colony-stimulating factor as first-line treatment for epithelial ovarian cancer: a phase I dose-intensity escalation study
A H Calvert, M J Lind, S Ghazal-Aswad, et al.
Journal of Medicinal Chemistry
|
November 1, 1990
Quinazoline antifolate thymidylate synthase inhibitors: benzoyl ring modifications in the C2-methyl series
P R Marsham, A L Jackman, J Oldfield, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1993
Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group
D R Newell, A D Pearson, K Balmanno, et al.
Page
of 15